Palvella Therapeutics, Inc. (PVLA)
146.15
-5.43
(-3.58%)
USD |
NASDAQ |
Oct 30, 16:00
145.98
-0.17
(-0.12%)
After-Hours: 20:00
Palvella Therapeutics Price : 146.15 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 149.49 | 150.90 | 144.10 | 146.15 | 293056.0 |
| Oct 29, 2026 | 149.65 | 156.82 | 146.47 | 151.58 | 342962.0 |
| Oct 28, 2026 | 134.15 | 147.91 | 132.94 | 147.47 | 368237.0 |
| Oct 27, 2026 | 126.31 | 133.33 | 125.62 | 132.91 | 178774.0 |
| Oct 26, 2026 | 126.52 | 127.20 | 123.83 | 126.23 | 110516.0 |
| Oct 23, 2026 | 124.60 | 125.93 | 121.34 | 125.10 | 164224.0 |
| Oct 22, 2026 | 125.09 | 127.91 | 123.48 | 126.39 | 104718.0 |
| Oct 21, 2026 | 125.39 | 128.48 | 122.82 | 126.58 | 255792.0 |
| Oct 20, 2026 | 123.30 | 131.03 | 122.54 | 123.92 | 267710.0 |
| Oct 19, 2026 | 121.93 | 125.08 | 120.75 | 122.96 | 271677.0 |
| Oct 16, 2026 | 127.27 | 127.27 | 118.22 | 120.30 | 182219.0 |
| Oct 15, 2026 | 123.58 | 129.49 | 122.51 | 127.34 | 240971.0 |
| Oct 14, 2026 | 125.53 | 128.29 | 120.27 | 122.58 | 384515.0 |
| Oct 13, 2026 | 134.08 | 134.14 | 127.97 | 128.51 | 215838.0 |
| Oct 12, 2026 | 137.27 | 138.48 | 131.78 | 134.38 | 213794.0 |
| Oct 09, 2026 | 130.70 | 139.86 | 128.80 | 138.77 | 174041.0 |
| Oct 08, 2026 | 129.90 | 131.95 | 124.49 | 131.34 | 209331.0 |
| Oct 07, 2026 | 125.97 | 131.34 | 125.00 | 130.59 | 151992.0 |
| Oct 06, 2026 | 133.75 | 133.85 | 124.97 | 128.00 | 309986.0 |
| Oct 05, 2026 | 132.50 | 133.26 | 129.51 | 132.16 | 142876.0 |
| Oct 02, 2026 | 135.15 | 137.04 | 127.26 | 132.47 | 348127.0 |
| Oct 01, 2026 | 135.57 | 139.23 | 131.65 | 132.73 | 343370.0 |
| Sep 30, 2026 | 141.14 | 142.96 | 137.30 | 137.93 | 262310.0 |
| Sep 29, 2026 | 140.20 | 141.54 | 136.18 | 139.00 | 215009.0 |
| Sep 28, 2026 | 138.13 | 143.55 | 137.42 | 139.83 | 188616.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arcus Biosciences, Inc. | 18.19 |
| Design Therapeutics, Inc. | 10.68 |
| Agenus, Inc. | 6.84 |
| Amgen, Inc. | 466.01 |
| Anika Therapeutics, Inc. | 20.95 |
Price Related Metrics
| Price to Book Value | 9.702 |
| Earnings Yield | -3.31% |
| Market Cap | 2.104B |